US EditionRSV vaccine access expanded to some people in their 50s, according to CDC website
- The CDC has expanded RSV vaccination eligibility to high-risk adults starting at age 50, down from age 60, as of June 25.
- This decision follows a recommendation from the Advisory Committee on Immunization Practices, which advised high-risk adults aged 50 and older to get vaccinated.
- Kennedy has appointed a new panel that has raised concerns among doctors' groups for its actions regarding vaccine policies.
- The new panel's actions alarmed doctors' groups due to their disregard for established science regarding vaccine preservatives.
52 Articles
52 Articles
In April, the influential Advisory Committee on Immunization Practices of CDC recommended expanding vaccination against SRV, but the decision was postponed
Linda Boyle: ACIP’s first meeting cuts through the noise on RSV and flu shots
By LINDA BOYLE The new members of the Advisory Committee on Immunization Practices (ACIP) met for two days to make recommendations on influenza and respiratory syncytial virus vaccinations for the 2025-2026 flu season. In opening Wednesday’s meeting, ACIP chair Martin Kulldorff, Ph.D., stated, “Some media outlets have been very harsh on the new members of […] The post Linda Boyle: ACIP’s first meeting cuts through the noise on RSV and flu shots …
Associated Press News
RSV vaccine access expanded to some people in their 50s, according to CDC website
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health Secretary Robert F.
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium
